Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variantをMicrobiology and Immunologyに発表しました!(池田研、Microbiology and Immunology)

Tsujino S#, Deguchi S#, Nomai T#, Padilla-Blanco M#, Plianchaisuk A#, Wang L#, Begum MM#, Uriu K# (#equal contribution), Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima Hi, Sasaki-Tabata K, Guo Z, Hinay Jr. AA, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T*, Takayama K*, Zahradnik J*, Hashiguchi T*, Fukuhara T*, Sato K* (*equal correspondence)

Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant

For more detail➡

 

HIV-1特異的CD8+細胞による感染fibrocytesの認識に関する研究が、Journal of Virology誌に掲載されました(滝口研と鈴研の共同研究)

Nozomi Kuse, Osamu Noyori, Naofumi Takahashi, Yu Zhang, Shinya Suzu, and Masafumi Takiguchi, Recognition of HIV-1-infected fibrocytes lacking Nef-mediated HLA-B downregulation by HIV-1-specific T cells. J Virol. 98: e00791-24, 2024

詳しくはこちら

Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIVをViruses に発表しました!(上野研、Viruses)

Isaac Ngare ,Toong Seng Tan 1,Mako Toyoda 1,Takeo Kuwata 1,Soichiro Takahama ,Eriko Nakashima 3,Naoya Yamasaki ,Chihiro Motozono 1,Teruhisa Fujii ,Rumi Minami ,Godfrey Barabona ,Takamasa Ueno

Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV

Viruses

For more detail➡

Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity.をFront Virol. に発表しました!(池田研、Front Virol. )

Begum MM, Ichihara K, Takahashi O, Nasser H, Jonathan M, Tokunaga K, Yoshida I, Nagashima M, Sadamasu K, Yoshimura K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Sato K, Ikeda T* (*correspondence)

Virological characteristics correlating with SARS-CoV-2 spike protein fusogenicity.

Front Virol.

Click for more details→

Assessing the efficacy of GO-anchored filters versus various commercial masks.をRSC Appl Interfacesに発表しました!(池田研、RSC Appl Interfaces)

Islam MS, Rabin NN, Begum MM, Goto N, Tagawa R, Nagashima M, Sadamasu K, Yoshimura K, Sekine Y, Ikeda T*, Hayami S* (*equal correspondence).

Assessing the efficacy of GO-anchored filters versus various commercial masks.

RSC Appl Interfaces

Click for more details→

Virological characteristics of the SARS-CoV-2 BA.2.86 variant.をCell Host Microbe.に発表しました!(池田研、Cell Host Microbe.)

Tamura T#, Mizuma K#, Nasser H#, Deguchi S#, Padilla-Blanco M#, Uriu K#, Tolentino JEM# (#equal contribution), Tsujino S, Suzuki R, Kojima I, Nao N, Shimizu R, Jonathan M, Kosugi Y, Guo Z, Hinay Jr. AA, Putri O, Kim Y, Tanaka YL, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Ito J, Irie T, Zahradnik J*, Ikeda T*, Takayama K*, Matsuno K*, Fukuhara T*, Sato K* (*equal correspondence).

Virological characteristics of the SARS-CoV-2 BA.2.86 variant.

Cell Host Microbe.

Click for more details 

ヒトレトロウイルス学共同研究センター
ヒトレトロウイルス学共同研究センター 鹿児島大学キャンパス
熊本大学キャンパス
生命化学研究部・教育部
IRCMS
ヒトレトロウイルス学共同研究センター 熊本キャンパス

Copyright @ 2019 Joint Research Center for Human Retrovirus Infection, Kumamoto University